Kingdon Capital logo

Kingdon Capital

North America, New York, United States, New York

Description

Kingdon Capital Management, L.L.C. is an employee owned hedge fund sponsor. The firm provides its services to high net worth individuals

Investor Profile

Kingdon Capital has made 17 investments, with 0 in the past 12 months and 18% as lead.

Stage Focus

  • Post Ipo Equity (24%)
  • Series B (18%)
  • Series C (18%)
  • Series D (12%)
  • Series E (6%)
  • Series A (6%)
  • Series Unknown (6%)
  • Debt Financing (6%)
  • Convertible Note (6%)

Country Focus

  • United States (82%)
  • Australia (6%)
  • Switzerland (6%)
  • Israel (6%)

Industry Focus

  • Biotechnology
  • Health Care
  • Medical
  • Therapeutics
  • Telecommunications
  • Pharmaceutical
  • Software
  • Manufacturing
  • Life Science
  • Mobile Devices
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Kingdon Capital frequently co-invest with?

Irving Investors
North America, Colorado, United States, Denver
Co-Investments: 2
Viola Ventures
Asia, Tel Aviv, Israel, Herzliya
Co-Investments: 2
Surveyor Capital
North America, Illinois, United States, Chicago
Co-Investments: 2
Van Wagoner Ventures, LLC
North America, California, United States, San Francisco
Co-Investments: 2
North Bridge Venture Partners & Growth Equity
North America, Massachusetts, United States, Wellesley
Co-Investments: 2
Ally Bridge Group
Asia, Hong Kong Island, Hong Kong, Hong Kong
Co-Investments: 1
Battery Ventures
North America, Massachusetts, United States, Boston
Co-Investments: 2
VC
North America, Georgia, United States, Alpharetta
Co-Investments: 2
Intel Capital
North America, California, United States, Santa Clara
Co-Investments: 2
FK
North America, Pennsylvania, United States, Pittsburgh
Co-Investments: 2

What are some of recent deals done by Kingdon Capital?

enVVeno Medical

Irvine, California, United States

enVVeno Medical is a clinical-stage medical device company focused on the advancement of innovative bioprosthetic solutions.

Clinical TrialsManufacturingMedical Device
Post Ipo EquityOct 6, 2023
Amount Raised: $28,000,000
Sapience Therapeutics

Scarsdale, New York, United States

Sapience Therapeutics is a preclinical-stage biotechnology company focused on advancing novel therapeutics for major unmet medical needs

BiotechnologyMedicalTherapeutics
Series BMay 31, 2022
Amount Raised: $41,000,000
Shoreline Biosciences

La Jolla, California, United States

Shoreline Biosciences is a biomedical company intended to establish immunotherapies for seriously ill patients.

BiotechnologyHealth CareLife ScienceMedical
Series BNov 2, 2021
Amount Raised: $140,000,000
Jasper Therapeutics

Redwood City, California, United States

Jasper Therapeutics is a biotechnology company that develops novel antibody therapies for stem cell transplants.

BiotechnologyHealth CarePharmaceuticalTherapeutics
Post Ipo EquitySep 27, 2021
Amount Raised: $100,000,000
CeQur Simplicity

Horw, Luzern, Switzerland

CeQur Simplicity develops drug delivery devices.

Health CareMedicalMedical Device
Series CApr 13, 2021
Amount Raised: $115,000,000
Imago BioSciences

San Carlos, California, United States

Imago is a clinical stage biopharmaceutical company that develops drugs for the management of proliferative diseases of the bone marrow.

BiotechnologyLife ScienceTherapeutics
Series CNov 19, 2020
Amount Raised: $80,000,000
Athenex

Buffalo, New York, United States

Athenex is a biopharmaceutical company that develops and discovers novel therapies for treating cancer and related conditions.

BiotechnologyMedicalPharmaceutical
Post Ipo EquityDec 5, 2019
Amount Raised: $60,000,000
Stealth BioTherapeutics

Newton, Massachusetts, United States

Stealth BioTherapeutics is a clinical-stage biotechnology company focused on genetic diseases.

BiopharmaBiotechnologyPharmaceuticalTherapeutics
Convertible NoteJun 18, 2018
Amount Raised: $100,000,000
SteadyMed Therapeutics

Tel Aviv, Tel Aviv, Israel

SteadyMed is a media-device company developing injectable therapeutic drugs for pain relief, diabetes and other chronic conditions.

BiotechnologyHealth CarePharmaceuticalTherapeutics
Post Ipo EquityApr 23, 2017
Amount Raised: $30,000,000
Napo Pharmaceuticals

San Francisco, California, United States

Napo Pharmaceuticals develops and commercializes proprietary pharmaceuticals in collaboration with local partners.

BiotechnologyCollaborationHealth CareMedical
Debt FinancingJan 3, 2017
Amount Raised: $2,000,000